Cohort Study on the Levels of Placental Growth Factor and Nucleosomes in Early Pregnancy and Adverse Pregnancy Outcomes
NCT07841197
Abortion, Habitual, Abortion, Spontaneous
View Trial DetailsNCT Number: NCT06567899
Preeclampsia is a dreadful disease with significant morbidity and mortality. Despite decades of research, we still need a proper diagnostic test or therapeutic option to treat this disorder. The proposed study will determine the diagnostic value of PBMC-secreted sFlt1 and determine the molecular mechanisms involved in its secretion. The molecular mechanisms can be novel therapeutic targets to treat this disorder.
Trial opening soon.
Get Notified18 year and older
Female
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Healthy Adults:
Non-Health Adults:
Pregnant Women:
Groups 3 - 6 will include pregnant women at different trimesters.
Criteria common to all groups:
Time frame: Outcome will be measured at 12 weeks, 24 weeks and 36 weeks of pregnancy.
sFLT1 levels in preeclampsia should be higher than normal pregnancy.
Trial opening soon.
Get NotifiedUniversity of Arizona
Other
Acronym: MUP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07841197
Abortion, Habitual, Abortion, Spontaneous
View Trial DetailsNCT07807098
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
View Trial DetailsNCT07793760
Cesarean Section, Female Urogenital Diseases and Pregnancy Complications
View Trial DetailsNCT07778966
Cardiovascular Diseases, Eclampsia
Birmingham, Alabama, United States
View Trial Details